A Kuster
Overview
Explore the profile of A Kuster including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
317
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Burda P, Kuster A, Hjalmarson O, Suormala T, Burer C, Lutz S, et al.
J Inherit Metab Dis
. 2015 Jan;
38(5):863-72.
PMID: 25633902
In the folate cycle MTHFD1, encoded by MTHFD1, is a trifunctional enzyme containing 5,10-methylenetetrahydrofolate dehydrogenase, 5,10-methenyltetrahydrofolate cyclohydrolase and 10-formyltetrahydrofolate synthetase activity. To date, only one patient with MTHFD1 deficiency, presenting...
2.
Sonnenberg D, Kuster A, Graf A, Heyn C, Hansen W
Nanotechnology
. 2014 May;
25(21):215602.
PMID: 24784358
Strain-free, vertically coupled GaAs quantum dots (QDs) with an ultra-low density below 1 × 10(7) cm(-2) are fabricated by filling of self-assembled nanoholes with a GaAs/AlGaAs/GaAs layer sequence. The sizes...
3.
Agerstrand M, Kuster A, Bachmann J, Breitholtz M, Ebert I, Rechenberg B, et al.
Environ Pollut
. 2011 Jul;
159(10):2487-92.
PMID: 21763042
Ecotoxicity data with high reliability and relevance are needed to guarantee the scientific quality of environmental risk assessments of pharmaceuticals. The main advantages of a more structured approach to data...
4.
Kuster A, Bachmann J, Brandt U, Ebert I, Hickmann S, Klein-Goedicke J, et al.
Regul Toxicol Pharmacol
. 2009 Jul;
55(3):276-80.
PMID: 19607869
The evaluation of the quality of data and their use within the review of environmental risk assessment of human as well as veterinary pharmaceuticals is described from a regulatory point...
5.
Mention K, Lacaille F, Valayannopoulos V, Romano S, Kuster A, Cretz M, et al.
Mol Genet Metab
. 2007 Oct;
93(1):40-3.
PMID: 17945525
We report here the 6- and 2-year follow-up of two patients diagnosed at 2 months of age with CDG-Ib who were treated with mannose, with digestive symptoms, liver involvement and...
6.
Gournay V, Roze J, Kuster A, Daoud P, Cambonie G, Hascoet J, et al.
Lancet
. 2004 Nov;
364(9449):1939-44.
PMID: 15567009
Background: Patent ductus arteriosus is a common complication of prematurity that frequently requires surgical or medical treatment. The benefit of prophylactic treatment by indometacin, a cyclo-oxygenase inhibitor, remains uncertain compared...
7.
Kuster A, Picherot G, Liet J, Hazart I, Poignant S
Arch Pediatr
. 2004 May;
11(6):689-91.
PMID: 15158882
No abstract available.
8.
Kuster A, Jouvet P, Bonnet D, FLANDIN C, Lenclein R, Hubert P, et al.
Eur J Pediatr Surg
. 2003 Nov;
13(5):294-7.
PMID: 14618517
Twenty-two premature neonates underwent surgical haemoclip closure of patent ductus arteriosus in a neonatal intensive care unit (NICU). Surgery was performed in the NICU in order to prevent hypothermia and...
9.
Gournay V, Savagner C, Thiriez G, Kuster A, Roze J
Lancet
. 2002 May;
359(9316):1486-8.
PMID: 11988250
We report three cases of severe hypoxaemia after ibuprofen administration during a randomised controlled trial of prophylactic treatment of patent ductus arteriosus with ibuprofen in premature infants born at less...
10.
Timmermann A, Pflanz S, Grotzinger J, Kuster A, Kurth I, Pitard V, et al.
FEBS Lett
. 2000 Feb;
468(2-3):120-4.
PMID: 10692570
Gp130 is the common signal transducing receptor subunit of interleukin (IL)-6, IL-11, leukemia inhibitory factor (LIF), oncostatin M (OSM), ciliary neurotrophic factor and cardiotrophin-1. IL-6 and IL-11 induce gp130 homodimerization...